Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 39 studies | 35% ± 14% | |
mast cell | 23 studies | 35% ± 15% | |
pericyte | 21 studies | 28% ± 8% | |
astrocyte | 20 studies | 46% ± 20% | |
smooth muscle cell | 14 studies | 28% ± 11% | |
connective tissue cell | 13 studies | 43% ± 16% | |
type I pneumocyte | 12 studies | 35% ± 11% | |
oligodendrocyte precursor cell | 12 studies | 38% ± 18% | |
myofibroblast cell | 10 studies | 30% ± 11% | |
endothelial cell | 10 studies | 34% ± 19% | |
epithelial cell | 10 studies | 36% ± 18% | |
adipocyte | 10 studies | 68% ± 16% | |
oligodendrocyte | 10 studies | 29% ± 11% | |
GABAergic neuron | 8 studies | 32% ± 10% | |
kidney loop of Henle epithelial cell | 7 studies | 45% ± 14% | |
macrophage | 7 studies | 29% ± 11% | |
interneuron | 6 studies | 29% ± 13% | |
neuron | 6 studies | 35% ± 17% | |
retinal ganglion cell | 6 studies | 40% ± 17% | |
Mueller cell | 6 studies | 44% ± 15% | |
secretory cell | 5 studies | 21% ± 9% | |
amacrine cell | 5 studies | 37% ± 25% | |
microglial cell | 5 studies | 26% ± 14% | |
kidney distal convoluted tubule epithelial cell | 5 studies | 46% ± 6% | |
retinal pigment epithelial cell | 5 studies | 58% ± 26% | |
cardiac muscle cell | 5 studies | 42% ± 4% | |
ciliated cell | 5 studies | 27% ± 11% | |
basal cell | 5 studies | 26% ± 10% | |
goblet cell | 5 studies | 31% ± 13% | |
natural killer cell | 4 studies | 18% ± 2% | |
pancreatic A cell | 4 studies | 41% ± 23% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 17% ± 2% | |
progenitor cell | 4 studies | 26% ± 7% | |
renal alpha-intercalated cell | 4 studies | 23% ± 7% | |
abnormal cell | 4 studies | 42% ± 12% | |
mesothelial cell | 4 studies | 39% ± 10% | |
glycinergic amacrine cell | 4 studies | 42% ± 19% | |
myeloid cell | 4 studies | 22% ± 4% | |
ON-bipolar cell | 4 studies | 21% ± 3% | |
hepatocyte | 4 studies | 49% ± 17% | |
muscle cell | 4 studies | 30% ± 16% | |
glutamatergic neuron | 4 studies | 39% ± 4% | |
club cell | 4 studies | 22% ± 6% | |
respiratory goblet cell | 4 studies | 34% ± 16% | |
renal principal cell | 4 studies | 39% ± 5% | |
pancreatic D cell | 3 studies | 63% ± 28% | |
type B pancreatic cell | 3 studies | 59% ± 19% | |
neural crest cell | 3 studies | 32% ± 4% | |
extravillous trophoblast | 3 studies | 33% ± 17% | |
rod bipolar cell | 3 studies | 23% ± 0% | |
acinar cell | 3 studies | 50% ± 17% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 27% ± 5% | |
pancreatic ductal cell | 3 studies | 40% ± 23% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 29% ± 6% | |
enteroendocrine cell | 3 studies | 31% ± 7% | |
intestinal crypt stem cell | 3 studies | 27% ± 6% | |
adventitial cell | 3 studies | 27% ± 3% | |
chondrocyte | 3 studies | 58% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 31% ± 11% | |
intestine | 7 studies | 27% ± 10% | |
eye | 7 studies | 25% ± 7% | |
lung | 6 studies | 24% ± 8% | |
kidney | 5 studies | 26% ± 7% | |
heart | 5 studies | 29% ± 7% | |
liver | 4 studies | 31% ± 12% | |
adipose | 4 studies | 41% ± 28% | |
pancreas | 3 studies | 55% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 6724.46 | 2618 / 2642 | 100% | 94.10 | 702 / 705 |
thymus | 100% | 3644.89 | 651 / 653 | 96% | 39.87 | 579 / 605 |
prostate | 100% | 5058.83 | 244 / 245 | 95% | 31.44 | 478 / 502 |
pancreas | 100% | 9898.88 | 328 / 328 | 88% | 24.04 | 157 / 178 |
skin | 96% | 6517.43 | 1740 / 1809 | 90% | 58.92 | 425 / 472 |
breast | 100% | 5937.86 | 459 / 459 | 85% | 36.56 | 954 / 1118 |
lung | 99% | 4167.78 | 572 / 578 | 83% | 25.61 | 960 / 1155 |
intestine | 100% | 4490.57 | 965 / 966 | 81% | 23.38 | 425 / 527 |
bladder | 100% | 4692.86 | 21 / 21 | 74% | 22.09 | 374 / 504 |
liver | 95% | 2266.52 | 214 / 226 | 77% | 16.25 | 311 / 406 |
stomach | 99% | 4395.71 | 355 / 359 | 71% | 18.50 | 202 / 286 |
adrenal gland | 100% | 7894.23 | 258 / 258 | 69% | 36.57 | 158 / 230 |
esophagus | 82% | 3166.18 | 1191 / 1445 | 73% | 18.41 | 133 / 183 |
kidney | 100% | 3007.21 | 89 / 89 | 51% | 12.38 | 458 / 901 |
uterus | 97% | 2914.54 | 165 / 170 | 52% | 15.62 | 240 / 459 |
ovary | 100% | 13980.44 | 180 / 180 | 30% | 4.94 | 131 / 430 |
adipose | 100% | 7474.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 3824.67 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 4146.06 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 48.68 | 76 / 80 |
spleen | 93% | 1938.31 | 225 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 2821.43 | 1235 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 12.84 | 26 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 3.16 | 8 / 29 |
peripheral blood | 17% | 616.94 | 159 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008584 | Biological process | male gonad development |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0030162 | Biological process | regulation of proteolysis |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RHOBTB3 |
Protein name | Rho-related BTB domain-containing protein 3 (EC 3.6.1.-) Rho related BTB domain containing 3 |
Synonyms | KIAA0878 |
Description | FUNCTION: Rab9-regulated ATPase required for endosome to Golgi transport. Involved in transport vesicle docking at the Golgi complex, possibly by participating in release M6PRBP1/TIP47 from vesicles to permit their efficient docking and fusion at the Golgi. Specifically binds Rab9, but not other Rab proteins. Has low intrinsic ATPase activity due to autoinhibition, which is relieved by Rab9. . |
Accessions | ENST00000510623.1 ENST00000506959.5 ENST00000379982.8 ENST00000510313.1 D6R935 H0Y9P6 ENST00000503737.1 H0YA85 ENST00000504179.5 O94955 H0Y8R9 D6RG10 ENST00000506817.1 H0Y9W9 D6RC79 ENST00000502541.1 H0Y9R7 ENST00000513091.1 H0Y9A8 ENST00000514198.1 |